Elevating Sirt1 levels and activating the AMPK pathway protect hepatocytes from lipid metabolic disorders such as NAFLD and suppress lipogenesis [46]. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.